Related references
Note: Only part of the references are listed.Expression of the epidermal growth factor system in endometrioid endometrial cancer
Kirsten Ejskjaer et al.
GYNECOLOGIC ONCOLOGY (2007)
EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcoma
CA Livasy et al.
GYNECOLOGIC ONCOLOGY (2006)
Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin
S Anastasi et al.
ONCOGENE (2005)
Dual role of AP-2γ in ErbB-2-induced mammary tumorigenesis
R Jäger et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Cyclooxygenase-2 is essential for HER2/neu to suppress N-(4-hydroxyphenyl)retinamide apoptotic effects in breast cancer cells
AM Simeone et al.
CANCER RESEARCH (2004)
HER-2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors
E Half et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2
SC Wang et al.
CANCER CELL (2004)
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
T Faltus et al.
NEOPLASIA (2004)
Share Paper
